| Dr Robert Blaine Hill, MD | |
|
3420 Kuhio Hwy, Lihue, HI 96766-1049 | |
| (808) 245-1075 | |
| (808) 245-1276 |
| Full Name | Dr Robert Blaine Hill |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 3420 Kuhio Hwy, Lihue, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508874611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD 2625 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Blaine Hill, MD 46-361 Holopu Pl, Kaneohe, HI 96744-4229 Ph: (808) 247-3466 | Dr Robert Blaine Hill, MD 3420 Kuhio Hwy, Lihue, HI 96766-1049 Ph: (808) 245-1075 |
News Archive
Kidney transplant recipients who develop antibodies in response to receiving new organs can develop accelerated arteriosclerosis, or narrowing of the arteries that supply blood to the kidney, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that arteriosclerosis resulting from such donor-specific antibodies may play an important role in organ rejection following transplantation.
These new findings, published online on the website of the journal Nature, point out that the harvest of stem cells for transplantation may be improved by timing it at the peak of their release.
Inovio Pharmaceuticals, Inc. announced today that it has achieved strong T cell immune responses in a Phase I clinical study of PENNVAX-B, its product for the treatment of the HIV subtype prevalent in North America and Europe, in HIV-positive subjects.
The study, which appears in the December 18 online version of Cell Stem Cell and the January 2009 print edition of the journal, provides proof of principle that alternative sources of stem cells can be created.
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian men with prostate cancer for 29 years. The results are now published in The New England Journal of Medicine.
› Verified 1 days ago
Yo Ho Shek, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3420 Kuhio Hwy, Lihue, HI 96766 Phone: 808-245-1075 Fax: 808-245-1276 |